12:00 AM
 | 
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Cytokinetics, GlaxoSmithKline preclinical data

In mouse xenograft models of advanced colon cancer, animals receiving 125 mg/kg of GSK-923295 had a 6% decrease in tumor volume during the first treatment cycle while those receiving 62.5 mg/kg had a 7% increase....

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >